Dashboard
Manage Tickers

SRPTSarepta Therapeutics, Inc.

Nasdaq sarepta.com


$ 129.75 $ 5.41 (4.35 %)    

Friday, 31-May-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 129.86
$ 125.40
$ 0.00 x 0
$ 140.55 x 125
$ 125.40 - $ 130.58
$ 55.25 - $ 146.68
16,923,760
na
12.87B
$ 0.80
$ 761.73
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/31/2024 17:35:21

piper-sandler-initiates-coverage-on-sarepta-therapeutics-with-overweight-rating-announces-price-target-of-157
Piper Sandler Initiates Coverage On Sarept...
05/31/2024 10:00:15

Piper Sandler analyst Biren Amin initiates coverage on Sarepta Therapeutics (NASDAQ:SRPT) with a Overweight rating and annou...

why-sarepta-therapeutics-stock-is-rising-today
Why Sarepta Therapeutics Stock Is Rising T...
05/30/2024 18:20:54

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added ...

Core News & Articles
Sarepta Therapeutics To Join S&P Midcap 40...
05/29/2024 21:20:31

 Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Mon...

sarepta-downgraded-as-fda-decision-date-approaches-shares-up-50-over-last-six-months
Sarepta Downgraded As FDA Decision Date Ap...
05/28/2024 18:39:54

RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recen...

why-applied-dna-sciences-shares-are-trading-lower-by-around-68-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Applied DNA Sciences Shares Are Tradin...
05/28/2024 17:24:16

rbc-capital-downgrades-sarepta-therapeutics-to-sector-perform-lowers-price-target-to-142
RBC Capital Downgrades Sarepta Therapeutic...
05/28/2024 10:13:44

RBC Capital analyst Brian Abrahams downgrades Sarepta Therapeutics (NASDAQ:SRPT) from Outperform to Sector Perform and lower...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/24/2024 17:35:24

jim-cramer-this-industrial-stock-is-doing-very-well-heres-his-take-on-palantir
Jim Cramer: This Industrial Stock Is Doing...
05/22/2024 12:50:59

Jim Cramer likes Enbridge Inc. (NYSE: ENB), says Lazard, Inc. (NYSE: LAZ) is a good buy, and Advanced Drainage Systems, Inc. (N...

12-analysts-have-this-to-say-about-sarepta-therapeutics
12 Analysts Have This To Say About Sarepta...
05/20/2024 13:01:29

needham-reiterates-buy-on-sarepta-therapeutics-maintains-166-price-target
Needham Reiterates Buy on Sarepta Therapeu...
05/20/2024 10:30:30

Needham analyst Gil Blum reiterates Sarepta Therapeutics (NASDAQ:SRPT) with a Buy and maintains $166 price target.

mizuho-maintains-buy-on-sarepta-therapeutics-raises-price-target-to-179
Mizuho Maintains Buy on Sarepta Therapeuti...
05/17/2024 11:43:15

Mizuho analyst Uy Ear maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Buy and raises the price target from $145 to $179.

oppenheimer-upgrades-sarepta-therapeutics-to-outperform-announces-180-price-target
Oppenheimer Upgrades Sarepta Therapeutics ...
05/14/2024 12:24:07

Oppenheimer analyst Hartaj Singh upgrades Sarepta Therapeutics (NASDAQ:SRPT) from Perform to Outperform and announces $180 p...

Core News & Articles
Sarepta Therapeutics Shares Move Higher; T...
05/07/2024 19:52:38

https://www.statnews.com/2024/05/07/duchenne-muscular-dystrophy-pfizer-gene-therapy-boy-dies/

jp-morgan-maintains-overweight-on-sarepta-therapeutics-lowers-price-target-to-175
JP Morgan Maintains Overweight on Sarepta ...
05/03/2024 18:52:25

JP Morgan analyst Anupam Rama maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Overweight and lowers the price target fro...

what-analysts-are-saying-about-sarepta-therapeutics-stock
What Analysts Are Saying About Sarepta The...
05/02/2024 21:00:45

cantor-fitzgerald-reiterates-neutral-on-sarepta-therapeutics-maintains-128-price-target
Cantor Fitzgerald Reiterates Neutral on Sa...
05/02/2024 16:13:11

Cantor Fitzgerald analyst Kristen Kluska reiterates Sarepta Therapeutics (NASDAQ:SRPT) with a Neutral and maintains $128 pri...

needham-reiterates-buy-on-sarepta-therapeutics-maintains-166-price-target
Needham Reiterates Buy on Sarepta Therapeu...
05/02/2024 10:51:16

Needham analyst Gil Blum reiterates Sarepta Therapeutics (NASDAQ:SRPT) with a Buy and maintains $166 price target.

apple-kellanova-and-3-stocks-to-watch-heading-into-thursday
Apple, Kellanova And 3 Stocks To Watch Hea...
05/02/2024 06:25:22

sarepta-therapeutics-q1-2024-adj-eps-073-beats-007-estimate-sales-413464m-beat-373283m-estimate
Sarepta Therapeutics Q1 2024 Adj EPS $0.73...
05/01/2024 20:25:01

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION